Marché européen de l’ophtalmologie – Tendances et prévisions du secteur jusqu’en 2030

Personnalisez votre rapport Personnalisez votre rapport Acheter maintenantAcheter maintenant Exemple de rapport gratuitExemple de rapport gratuit
Maison Medical Devices Europe Ophthalmology Market
Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché européen de l’ophtalmologie – Tendances et prévisions du secteur jusqu’en 2030

  • Medical Devices
  • Publish Reports
  • Jan 2023
  • Europe
  • 350 Pages
  • Nombre de tableaux : 571
  • Nombre de figures : 47
Buy Now Acheter maintenant

Europe Ophthalmology Market

Taille du marché en milliards USD

TCAC :  % Diagram

Diagram Période de prévision
 2023 –2030
Diagram Taille du marché (année de référence)
 USD 14,789.41 Million
Diagram Taille du marché (année de prévision)
 USD 23,186.51 Million
Diagram TCAC
 %
DiagramPrincipaux acteurs du marché
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5 < /li>
Demande de déverrouillage

>Marché européen de l'ophtalmologie, par produit (dispositif, médicaments et autres), maladies (glaucome, cataracte, dégénérescence maculaire liée à l'âge, maladies inflammatoires, troubles de la réfraction et autres), mode de prescription (générique et de marque), type de médicament (sur ordonnance et en vente libre), voie d'administration (orale, topique, injectables, oculaire locale et autres), utilisateur final (hôpitaux, cliniques, soins à domicile et autres), canal de distribution (appel d'offres direct, vente au détail et autres) - Tendances et prévisions de l'industrie jusqu'en 2030.

Marché européen de l'ophtalmologie

Analyse et taille du marché de l'ophtalmologie en Europe

L'un des principaux facteurs à l'origine de la croissance du marché de l'ophtalmologie est la prévalence croissante des troubles ophtalmiques et des douleurs oculaires. Les recherches cliniques continues menées par plusieurs entreprises pharmaceutiques pour améliorer les choix de traitement et l'exposition à certaines toxines ou changements environnementaux augmentent la fréquence des produits ophtalmologiques et conduisent à l'expansion du marché. Le marché est également influencé par des modes de vie de plus en plus insalubres et sédentaires et par une augmentation des blessures traumatiques. Cependant, le coût élevé et les risques associés à la chirurgie et au traitement oculaires, le manque d'assurance maladie au sein de la population, en particulier dans les pays en développement, et la période prolongée de fabrication et de formulation des médicaments ophtalmiques constituent des facteurs restrictifs pour le marché européen de l'ophtalmologie au cours de la période de prévision.

Marché européen de l'ophtalmologie

Marché européen de l'ophtalmologie

Le marché européen de l'ophtalmologie devrait connaître une croissance de marché au cours de la période de prévision de 2023 à 2030. Data Bridge Market Research analyse que le marché croît avec un TCAC de 5,8 % au cours de la période de prévision de 2023 à 2030 et devrait atteindre 23 186,51 millions USD d'ici 2030, contre 14 789,41 millions USD en 2022.

Rapport métrique

Détails

Période de prévision

2023 à 2030

Année de base

2022

Années historiques

2021 (personnalisable de 2015 à 2020)

Unités quantitatives

Chiffre d'affaires en millions USD

Segments couverts

Par type de produit (dispositif, médicaments et autres), maladies ( glaucome , cataracte, dégénérescence maculaire liée à l'âge, maladies inflammatoires, troubles de la réfraction et autres), mode de prescription (générique et de marque), type de médicament (sur ordonnance et en vente libre (OTC)), voie d'administration (orale, topique, injectables, oculaire locale et autres), utilisateur final (hôpitaux, cliniques, soins de santé à domicile et autres), canal de distribution (appel d'offres direct, vente au détail et autres)

Pays couverts

Russie, Espagne, Turquie, Allemagne, Italie, Royaume-Uni, France, Hongrie, Autriche, Suisse, Pays-Bas, Pologne, Irlande, Norvège, Lituanie, Reste de l'Europe

Acteurs du marché couverts

Alcon, Regeneron Pharmaceuticals Inc., Johnson & Johnson, Inc., Reichert, Inc., Novartis AG, Bausch & Lomb Incorporated, HOYA Corporation., The Cooper Companies Inc., Santen Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd, Carl Zeiss Meditec AG, AbbVie Inc., EssilorLuxottica, NIDEK CO., LTD., TOPCON CORPORATION, Glaukos Corporation., STAAR SURGICAL, Metall Zug AG, Sun Pharmaceutical Industries Ltd., Lumenis Be Ltd., Pfizer Inc., and Ziemer Ophthalmic Systems AG, among others.

Market Definition

Ophthalmology is a branch of medicine that deals with the anatomy, physiology, treatment and surgery of the visual pathways of the eye, including surrounding areas and the visual aspects of the brain. Ophthalmic devices are medical equipment designed for surgery, diagnosis, and vision correction. The devices gained increased importance and adoption due to the high prevalence of several ophthalmic diseases, such as glaucoma, cataract, and other vision-related issues. Ophthalmic drugs are medications that are specially designed and administered for the treatment of various eye-related disorders, including color blindness, diabetic macular edema, cytomegalovirus (CMV), and age-related macular degeneration (AMD). 

Ophthalmology Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

  • Rising prevalence of ophthalmic disorders & ocular pains

Ophthalmic disorders are the vital cause of major ocular and orbital pains in the eye. Ocular pain occurs over the surface of the eyes along with symptoms such as scratching, burning, or itching sensation. This may be due to multiple reasons, including irritation from foreign objects, infection or trauma. Eyelashes or pieces of dirt, smoke, dust or some harsh eye cosmetics are the common causes leading to ocular pain, redness, and watery eyes.

The prevalence of ocular pain keeps showing a surge in growth as chemical industries and pollution around the world are growing. Chemical burns and flash burns cause significant and severe ocular pain due to irritations over the eye surface. Style and blepharitis lead to severe ocular pain as they cause eye and oil glands to be more sensitive around the area. The affirmative factor states that this is the major driver for the Europe ophthalmology market.

  • Rise in traumatic injuries

Traumatic head injury is one of the causes of such disorders as optic nerve disorders. A traumatic injury is a physical injury that occurs suddenly with a certain degree of severity. Trauma can be caused by a variety of external injuries. The most common causes of traumatic injury include road accidents, sports injuries, and violence, among others which can lead to some serious eye disorders as well. The prevalence of such traumatic injuries is highly seen worldwide.

Hence, such traumatic injuries lead to optic nerve disorders, which are affecting the population in these years and it is increasing with the rising population. Therefore, a rise in traumatic injuries is expected to drive market growth.

Opportunities

  • Rise in healthcare expenditure and disposable income

Healthcare expenditure and its growth rate over time are inclined by a wide variety of economic and social factors, including the financing arrangements and structure of the organization of the health system.

Healthcare expenditure has increased across the world as people's disposable income in various countries is increasing. Moreover, to accomplish the population requirements, government bodies and healthcare organizations are taking initiatives by virtue of accelerating healthcare expenditure.

Growing healthcare expenditure is also beneficial for further economic growth and healthcare sector growth. It is primarily fruitful as it significantly affects the development of better and more advanced medical products in the market. Therefore, the surge in healthcare expenditure may act as a great opportunity for market growth.

  • Rising awareness to prevent the burden of eye diseases

Significant advancements in the prevention of visual impairment have been made to battle visible diseases by various organizations such as World Health Organization (WHO) and its Member States, UN agencies, Non-Governmental Organizations (NGOs) and the private sector. Therefore, the second Thursday of October is World Sight Day (WSD), an annual awareness day to create Europe attention on blindness and vision impairment.

Thus, the programs and initiatives to reduce the burden of eye diseases are expected to create opportunities for the growth of the Europe ophthalmology market in the forecast period.

Restraints/Challenges

  • High cost & risks associated with eye surgery & treatment

The cost of the various disorders treatment plays a major role in the market. The optic nerve disorders treatments are highly sophisticated, as the prevalence of such disorders is increasing; hence the need for such products has eventually raised, thereby raising the treatment cost, which can hinder the market growth in the coming years.

There are various methods for the treatment of optic neuritis disorder. Some of them are patients can take various medicines such as corticosteroids like methylprednisolone, prednisone, immunoglobulin, vitamin B12 shots and various other surgeries. With these, there are some of the risks associated with it.

Therefore, for some of the population around the country, it is difficult for them to undergo such treatments due to the high cost. Hence, the high cost associated with ophthalmic disorders treatment is expected to restrain market growth.

  • Lack of skilled professionals

The number of ophthalmologists in both emerging and industrialized countries is minor. However, projections are a little higher for developing countries. The number of ophthalmologists is cumulative but not as fast as the population of elderly patients aged 60 years or older who need to be amplified ophthalmologic care. In most countries, the problem is that demographic changes do not match up with professional development. It is required to train eye care teams to meet the current number of ophthalmologists worldwide. The increased need for ophthalmologists globally also reflects an increase in the cases of diabetes. Diabetic patients should get their eyes inspected every year. The increasing demand for ophthalmologists is directly proportional to the growing geriatric population since eye care is an integral part of healthcare. The access to care gaps can be met by combining factors, including more efficient practice structures, processes and appropriate use of technology.

Post-COVID-19 Impact on the Ophthalmology Market

The COVID-19 pandemic had a great impact on the ophthalmology and surgical industries. Trade groups in the ophthalmic and vision products sector claim that the Europe supply chain for operating, diagnostic and vision care products has been significantly damaged, impacting end-user consumption of the ophthalmology market. Sales of vision care products in the first quarter of 2020 were significantly delayed due to logistical and transportation issues. On the demand side, the market is increasing as people have to get operated after the lockdown scenario. The situation needs to be taken into consideration, and emergency operations need to be operated. Furthermore, on the supply side, the growth of the market is on a negative scale. This is due to the lockdown situations in many countries manufacturing diagnostic, operating and vision care instruments.

Recent Developments

  • In October 2022, Regeneron Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for EYLEA (aflibercept) Injection to treat Retinopathy of Prematurity (ROP) in preterm infants. This development helps the organization in developing its brand image in the ophthalmology market, among others
  • In May 2022, Reichert, Inc. has launched its redesigned refractometers & analytical instruments website with a vastly improved user experience

Europe Ophthalmology Market Scope

The Europe ophthalmology market is segmented into products, disease, prescription mode, drug type, route of administration, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Products

  • Device
  • Drugs
  • Others

On the basis of products, the ophthalmology market is segmented into devices, drugs, and others.

Diseases

  • Glaucoma
  • Cataract
  • Age-Related Macular Degeneration
  • Inflammatory Diseases
  • Refractive Disorders
  • Others

On the basis of diseases, the ophthalmology market is segmented into glaucoma, cataracts, age-related macular degeneration, inflammatory diseases, refractive disorders, and others.

Prescription Mode

  • Generic
  • Branded

On the basis of prescription mode, the ophthalmology market is segmented into generic and branded.

Drug Type

  • Prescription
  • Over the Counter (OTC)

On the basis of drug type, the ophthalmology market is segmented into prescription and over-the-counter (OTC).

Route of Administration

  • Oral
  • Topical
  • Injectables
  • Local Ocular
  • Others

On the basis of route of administration, the ophthalmology market is segmented into oral, topical, injectables, local ocular and others.

End User

  • Hospitals
  • Clinics
  • Home Healthcare
  • Others

On the basis of end user, the ophthalmology market is segmented into hospitals, clinics, home healthcare, and others.

Distribution Channel

  • Direct Tender
  • Retail Sales
  • Others

On the basis of distribution channels, the ophthalmology market is segmented into direct tender, retail sales, and others.

Ophthalmology Market Regional Analysis/Insights                           

The Europe ophthalmology market is segmented on the basis of products, disease, prescription mode, drug type, route of administration, end user, and distribution channel.

The countries in the Europe gaskets market are Germany, Italy, United Kingdom, France, Hungary, Austria, Switzerland, Netherlands, Poland, Ireland, Norway, Lithuania, and Rest of Europe. 

Russia is dominating because of the demand for ophthalmology products and an increase in research and development activities in the industry are also expected to drive the market in the forecasted period.

The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data point downstream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Europe Ophthalmology Market Share Analysis

Le paysage concurrentiel du marché de l'ophtalmologie fournit des détails par concurrents. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence en Europe, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit et la domination des applications. Les points de données ci-dessus fournis ne concernent que les entreprises se concentrant sur le marché européen de l'ophtalmologie.

Français Certains des principaux acteurs opérant sur ce marché sont Alcon, Regeneron Pharmaceuticals Inc., Johnson & Johnson, Inc., Reichert, Inc., Novartis AG, Bausch & Lomb Incorporated, HOYA Corporation., The Cooper Companies Inc., Santen Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd, Carl Zeiss Meditec AG, AbbVie Inc., EssilorLuxottica, NIDEK CO., LTD., TOPCON CORPORATION, Glaukos Corporation., STAAR SURGICAL, Metall Zug AG, Sun Pharmaceutical Industries Ltd., Lumenis Be Ltd., Pfizer Inc. et Ziemer Ophthalmic Systems AG, entre autres.

SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

Sample Image Cliquez sur l'image pour l'agrandir
  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE OPHTHALMOLOGY MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 EUROPE OPHTHALMOLOGY MARKET: SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT SEGMENT LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

5 EPIDEMIOLOGY

6 STRATEGIC INITIATIVES

7 EUROPE OPHTHALMOLOGY MARKET, REGULATION

8 MARKET OVERVIEW

8.1 DRIVERS

8.1.1 RISING PREVALENCE OF OPHTHALMIC DISORDERS & OCULAR PAINS

8.1.2 INCREASING UNHYGIENIC & SEDENTARY LIFESTYLE

8.1.3 RISE IN TRAUMATIC INJURIES

8.1.4 RISE IN THE GERIATRIC POPULATION

 

8.2 RESTRAINTS

8.2.1 HIGH COST & RISKS ASSOCIATED WITH EYE SURGERY & TREATMENT

8.2.2 LACK OF HEALTH INSURANCE AMONGST THE POPULATION, ESPECIALLY WITHIN THE DEVELOPING COUNTRIES

8.2.3 SIDE EFFECTS ASSOCIATED WITH TREATMENT DRUGS

8.3 OPPORTUNITIES

8.3.1 RISE IN HEALTHCARE EXPENDITURE AND DISPOSABLE INCOME

8.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS

8.3.3 RISING AWARENESS TO PREVENT THE BURDEN OF EYE DISEASES

8.4 CHALLENGE

8.4.1 LACK OF SKILLED PROFESSIONALS

8.4.2 STRINGENT RULES & REGULATIONS FOR PRODUCT APPROVAL

9 EUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS

9.1 OVERVIEW

9.2 DEVICE

9.2.1 SURGICAL DEVICE

9.2.1.1 CATARACT SURGICAL DEVICES

9.2.1.2 OPHTHALMIC VISCOELASTIC DEVICES

9.2.1.2.1 PHACOEMULSIFICATION DEVICES

9.2.1.2.2 CATARACT SURGICAL LASERS

9.2.1.2.3 IOL INJECTORS

9.2.1.3 VITREORETINAL SURGICAL DEVICES

9.2.1.3.1 VITREORETINAL PACKS

9.2.1.3.2 VITRECTOMY MACHINES

9.2.1.3.3 VITRECTOMY PROBES

9.2.1.3.4 PHOTOCOAGULATION LASERS

9.2.1.3.5 ILLUMINATION DEVICES

9.2.1.4 REFRACTIVE SURGICAL DEVICES

9.2.1.4.1 FEMTOSECOND LASERS

9.2.1.4.2 EXCIMER LASERS

9.2.1.4.3 OTHER REFRACTIVE SURGICAL LASERS

9.2.1.5 GLAUCOMA SURGICAL DEVICES

9.2.1.5.1 GLAUCOMA DRAINAGE DEVICES

9.2.1.5.2 GLAUCOMA LASER SYSTEMS

9.2.1.5.3 MICRO INVASIVE GLAUCOMA SURGERY DEVICES

 

9.2.2 DIAGNOSTIC DEVICE

9.2.2.1 AUTOREFRACTORS & KERATOMETERS

9.2.2.2 TONOMETER

9.2.2.3 PHOROPTERS

9.2.2.4 RETINOSCOPES

9.2.2.5 OPHTHALMOSCOPES

9.2.2.6 PERIMETERS/VISUAL FIELD ANALYZERS

9.2.2.7 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS

9.2.2.7.1 A- SCAN IMAGING SYSTEM

9.2.2.7.2 B-SCAN IMAGING SYSTEM

9.2.2.7.3 PACHYMETERS

9.2.2.7.4 ULTRASOUND BIOMICROSCOPES

9.2.2.8 LENSMETERS

9.2.2.9 CORNEAL TOPOGRAPHY SYSTEMS

9.2.2.10 OPTICAL COHERENCE TOMOGRAPHY SCANNERS

9.2.2.11 FUNDUS CAMERAS

9.2.2.12 OPTICAL BIOMETRY SYSTEMS

9.2.2.13 SPECULAR MICROSCOPES

9.2.2.14 WAVEFRONT ABERROMETERS

9.2.2.15 CHART PROJECTORS

9.2.2.16 SLIT LAMPS

9.2.3 OPHTHALMIC SURGICAL ACCESSORIES

9.2.3.1 SURGICAL INSTRUMENTS & KITS

9.2.3.2 OPHTHALMIC FORCEPS

9.2.3.3 OPHTHALMIC SPATULA

9.2.3.4 OPHTHALMIC TIPS AND HANDLES

9.2.3.5 OPHTHALMIC CANNULAS

9.2.3.6 OPHTHALMIC SCISSORS

9.2.3.7 OTHERS SURGICAL ACCESSORIES

9.2.4 OPHTHALMIC MICROSCOPES

9.3 DRUGS

9.3.1 ANTI-INFLAMMATION DRUGS

9.3.1.1 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

9.3.1.2 STEROIDAL ANTI-INFLAMMATORY DRUGS

9.3.2 ALLERGIC CONJUNCTIVITIS

9.3.3 DRY EYE DRUGS

9.3.4 RETINAL DISORDER DRUGS

 

9.3.5 ANTI-GLAUCOMA DRUGS

9.3.5.1 MIOTICS

9.3.5.1.1 PILOCARPINE

9.3.5.1.2 ESERINE

9.3.5.2 BETA ADRENERGIC ANTAGONISTS

9.3.5.2.1 TIMOLAL MALEATE

9.3.5.2.2 BETAXOLOL

9.3.5.3 PROSTAGLANDIN ANALOGS

9.3.5.3.1 LATANOPROST

9.3.5.3.2 BIMATOPROST

9.3.5.3.3 TRAVOPROST

9.3.5.3.4 TAFLUPROST

9.3.5.3.5 LATANOPROSTENE

9.3.5.4 ALPHA ADRENERGIC AGONISTS

9.3.5.4.1 EPINEPHRINE

9.3.5.4.2 DEPIVEPRINE

9.3.5.5 ANTI-VEGF DRUGS

9.3.5.5.1 RANIBIZUMAB

9.3.5.5.2 BEVACIZUMAB

9.3.6 OTHERS

9.4 OTHERS

9.4.1 VISION CARE PRODUCTS

9.4.1.1 SPECTACLES

9.4.1.2 CONTACT LENSES

9.4.1.2.1 SOFT CONTACT LENSES

9.4.1.2.2 HYBRID CONTACT LENSES

9.4.1.2.3 RIGID GAS PERMEABLE LENSES

9.4.2 OTHERS

10 EUROPE OPHTHALMOLOGY MARKET, BY DISEASES

10.1 OVERVIEW

10.2 INFLAMMATORY DISEASES

10.3 CATARACT

10.4 REFRACTIVE DISORDERS

10.5 GLAUCOMA

10.6 AGE-RELATED MACULAR DEGENERATION

10.7 OTHERS

 

11 EUROPE OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE

11.1 OVERVIEW

11.2 BRANDED

11.3 GENERIC

12 EUROPE OPHTHALMOLOGY MARKET, BY DRUG TYPE

12.1 OVERVIEW

12.2 OVER THE COUNTER

12.3 PRESCRIPTION

13 EUROPE OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION

13.1 OVERVIEW

13.2 TOPICAL

13.2.1 EYE DROPS

13.2.2 EYE SOLUTION

13.2.3 CREAM & OINTMENTS

13.2.4 GEL

13.2.5 OTHERS

13.3 ORAL

13.3.1 TABLET

13.3.2 CAPSULES

13.3.3 OTHERS

13.4 LOCAL OCULAR

13.4.1 SUBCONJUNCTIVAL

13.4.2 INTRAVITREAL

13.4.3 RETROBULBAR

13.4.4 INTRACAMERAL

13.5 INJECTABLE

13.5.1 INTRAMUSCULAR

13.5.2 INTRAVENOUS

13.5.3 OTHERS

13.6 OTHERS

14 EUROPE OPHTHALMOLOGY MARKET, BY END USER

14.1 OVERVIEW

14.2 CLINICS

14.3 HOSPITALS

14.4 HOMECARE SETTINGS

14.5 OTHERS

 

15 EUROPE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL

15.1 OVERVIEW

15.2 RETAIL SALES

15.2.1 RETAIL SHOPS

15.2.2 HOSPITAL PHARMACY

15.2.3 ONLINE PHARMACY

15.3 DIRECT TENDER

15.4 OTHERS

16 EUROPE OPHTHALMOLOGY MARKET, BY GEOGRAPHY

16.1 EUROPE

16.1.1 GERMANY

16.1.2 U.K.

16.1.3 FRANCE

16.1.4 HUNGARY

16.1.5 LITHUANIA

16.1.6 AUSTRIA

16.1.7 IRELAND

16.1.8 NORWAY

16.1.9 POLAND

16.1.10 ITALY

16.1.11 SPAIN

16.1.12 RUSSIA

16.1.13 TURKEY

16.1.14 NETHERLANDS

16.1.15 SWITZERLAND

16.1.16 REST OF EUROPE

17 EUROPE OPHTHALMOLOGY MARKET: COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: EUROPE

18 SWOT ANALYSIS

19 COMPANY PROFILE

19.1 ALCON

19.1.1 COMPANY SNAPSHOT

19.1.2 RECENT FINANCIALS

19.1.3 COMPANY SHARE ANALYSIS

19.1.4 PRODUCT PORTFOLIO

19.1.5 RECENT DEVELOPMENTS

 

19.2 REGENERON PHARMACEUTICALS INC.

19.2.1 COMPANY SNAPSHOT

19.2.2 RECENT FINANCIALS

19.2.3 COMPANY SHARE ANALYSIS

19.2.4 PRODUCT PORTFOLIO

19.2.5 RECENT DEVELOPMENT

19.3 JOHNSON & JOHNSON SERVICES, INC.

19.3.1 COMPANY SNAPSHOT

19.3.2 RECENT FINANCIALS

19.3.3 COMPANY SHARE ANALYSIS

19.3.4 PRODUCT PORTFOLIO

19.3.5 RECENT DEVELOPMENT

19.4 REICHERT, INC.

19.4.1 COMPANY SNAPSHOT

19.4.2 COMPANY SHARE ANALYSIS

19.4.3 PRODUCT PORTFOLIO

19.4.4 RECENT DEVELOPMENT

19.5 NOVARTIS AG

19.5.1 COMPANY SNAPSHOT

19.5.2 REVENUE ANALYSIS

19.5.3 COMPANY SHARE ANALYSIS

19.5.4 PRODUCT PORTFOLIO

19.5.5 RECENT DEVELOPMENTS

19.6 ABBVIE INC.

19.6.1 COMPANY SNAPSHOT

19.6.2 RECENT FINANCIALS

19.6.3 PRODUCT PORTFOLIO

19.6.4 RECENT DEVELOPMENT

19.7 BAUSCH & LOMB INCORPORATED

19.7.1 COMPANY SNAPSHOT

19.7.2 REVENUE ANALYSIS

19.7.3 PRODUCT PORTFOLIO

19.7.4 RECENT DEVELOPMENTS

19.8 CARL ZEISS MEDITEC AG

19.8.1 COMPANY SNAPSHOT

19.8.2 REVENUE ANALYSIS

19.8.3 PRODUCT PORTFOLIO

19.8.4 RECENT DEVELOPMENTS

 

19.9 ESSILORLUXOTTICA

19.9.1 COMPANY SNAPSHOT

19.9.2 REVENUE ANALYSIS

19.9.3 PRODUCT PORTFOLIO

19.9.4 RECENT DEVELOPMEN

19.1 F. HOFFMANN- LA ROCHE LTD

19.10.1 COMPANY SNAPSHOT

19.10.2 REVENUE ANALYSIS

19.10.3 PRODUCT PORTFOLIO

19.10.4 RECENT DEVELOPMENT

19.11 GLAUKOS

19.11.1 COMPANY SNAPSHOT

19.11.2 REVENUE ANALYSIS

19.11.3 PRODUCT PORTFOLIO

19.11.4 RECENT DEVELOPMENTS

19.12 HEIDELBERG ENGINEERING GMBH

19.12.1 COMPANY SNAPSHOT

19.12.2 PRODUCT PORTFOLIO

19.12.3 RECENT DEVELOPMENT

19.13 HOYA CORPORATION

19.13.1 COMPANY SNAPSHOT

19.13.2 REVENUE ANALYSIS

19.13.3 PRODUCT PORTFOLIO

19.13.4 RECENT DEVELOPMENTS

19.14 LUMENIS BE LTD.

19.14.1 COMPANY SNAPSHOT

19.14.2 PRODUCT PORTFOLIO

19.14.3 RECENT DEVELOPMENT

19.15 METALL ZUG AG

19.15.1 COMPANY SNAPSHOT

19.15.2 REVENUE ANALYSIS

19.15.3 PRODUCT PORTFOLIO

19.15.4 RECENT DEVELOPMENT

19.16 NEOVISION

19.16.1 COMPANY SNAPSHOT

19.16.2 PRODUCT PORTFOLIO

19.16.3 RECENT DEVELOPMENT

 

19.17 NIDEK CO., LTD.

19.17.1 COMPANY SNAPSHOT

19.17.2 PRODUCT PORTFOLIO

19.17.3 RECENT DEVELOPMENT

19.18 PFIZER INC.

19.18.1 COMPANY SNAPSHOT

19.18.2 REVENUE ANALYSIS

19.18.3 PRODUCT PORTFOLIO

19.18.4 RECENT DEVELOPMENT

19.19 SANTEN PHARMACEUTICAL CO., LTD.

19.19.1 COMPANY SNAPSHOT

19.19.2 RECENT FINANCIALS

19.19.3 PRODUCT PORTFOLIO

19.19.4 RECENT DEVELOPMENTS

19.2 SUN PHARMACEUTICAL INDUSTRIES LTD.

19.20.1 COMPANY SNAPSHOT

19.20.2 RECENT FINANCIALS

19.20.3 PRODUCT PORTFOLIO

19.20.4 RECENT DEVELOPMENTS

19.21 STAAR SURGICAL

19.21.1 COMPANY SNAPSHOT

19.21.2 REVENUE ANALYSIS

19.21.3 PRODUCT PORTFOLIO

19.21.4 RECENT DEVELOPMENTS

19.22 THE COOPER COMPANIES INC.

19.22.1 COMPANY SNAPSHOT

19.22.2 REVENUE ANALYSIS

19.22.3 PRODUCT PORTFOLIO

19.22.4 RECENT DEVELOPMENTS

19.23 TOPCON CORPORATION

19.23.1 COMPANY SNAPSHOT

19.23.2 REVENUE ANALYSIS

19.23.3 PRODUCT PORTFOLIO

19.23.4 RECENT DEVELOPMENTS

19.24 VISIONIX

19.24.1 COMPANY SNAPSHOT

19.24.2 PRODUCT PORTFOLIO

19.24.3 RECENT DEVELOPMENT

 

19.25 ZIEMER OPHTHALMIC SYSTEMS AG

19.25.1 COMPANY SNAPSHOT

19.25.2 PRODUCT PORTFOLIO

19.25.3 RECENT DEVELOPMENTS

20 QUESTIONNAIRE

21 RELATED REPORTS

Liste des tableaux

TABLE 1 EUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 2 EUROPE DEVICE IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 3 EUROPE DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 4 EUROPE SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 5 EUROPE OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 6 EUROPE VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 7 EUROPE REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 8 EUROPE GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 9 EUROPE DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 10 EUROPE OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 11 EUROPE OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 12 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 13 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 14 EUROPE ANTI INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 15 EUROPE ANTI GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 16 EUROPE MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 17 EUROPE BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 18 EUROPE PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 19 EUROPE ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 20 EUROPE ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 21 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 22 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 23 EUROPE VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 24 EUROPE CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION))

TABLE 25 EUROPE OPHTHALMOLOGY MARKET, BY DISEASES 2021-2030 (USD MILLION)

TABLE 26 EUROPE INFLAMMATORY DISEASES IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 27 EUROPE CATARACT IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 28 EUROPE REFRACTIVE DISORDERS IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 29 EUROPE GLAUCOMA IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 30 EUROPE AGE-RELATED MACULAR DEGENERATION IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 31 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 32 EUROPE OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 33 EUROPE BRANDED IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 34 EUROPE GENERIC IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 35 EUROPE OPHTHALMOLOGY MARKET, BY DRUG TYPE 2021-2030 (USD MILLION)

TABLE 36 EUROPE OVER THE COUNTER IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 37 EUROPE PRESCRIPTION IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 38 EUROPE OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 39 EUROPE TOPICAL IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 40 EUROPE TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 41 EUROPE ORAL IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 42 EUROPE ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 43 EUROPE LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 44 EUROPE LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 45 EUROPE INJECTABLES IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 46 EUROPE INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 47 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 48 EUROPE OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 49 EUROPE CLINICS IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 50 EUROPE HOSPITALS IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 51 EUROPE HOME HEALTHCARE IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 52 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 53 EUROPE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 54 EUROPE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 55 EUROPE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL 2021-2030 (USD MILLION)

TABLE 56 EUROPE DIRECT TENDER IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 57 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 58 EUROPE OPHTHALMOLOGY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 59 EUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 60 EUROPE DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 61 EUROPE SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 62 EUROPE OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 63 EUROPE VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 64 EUROPE REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 65 EUROPE GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 66 EUROPE DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 67 EUROPE OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 68 EUROPE OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 69 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 70 EUROPE ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 71 EUROPE ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 72 EUROPE MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 73 EUROPE BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 74 EUROPE PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 75 EUROPE ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 76 EUROPE ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 77 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 78 EUROPE VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 79 EUROPE CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 80 EUROPE OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 81 EUROPE OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 82 EUROPE OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 83 EUROPE OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 84 EUROPE TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 85 EUROPE ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 86 EUROPE LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 87 EUROPE INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 88 EUROPE OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 89 EUROPE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 90 EUROPE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 91 GERMANY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 92 GERMANY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 93 GERMANY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 94 GERMANY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 95 GERMANY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 96 GERMANY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 97 GERMANY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 98 GERMANY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 99 GERMANY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 100 GERMANY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 101 GERMANY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 102 GERMANY ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 103 GERMANY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 104 GERMANY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 105 GERMANY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 106 GERMANY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 107 GERMANY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 108 GERMANY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 109 GERMANY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 110 GERMANY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 111 GERMANY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 112 GERMANY OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 113 GERMANY OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 114 GERMANY OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 115 GERMANY OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 116 GERMANY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 117 GERMANY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 118 GERMANY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 119 GERMANY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 120 GERMANY OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 121 GERMANY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 122 GERMANY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 123 U.K. OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 124 U.K. DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 125 U.K. SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 126 U.K. OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 127 U.K. VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 128 U.K. REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 129 U.K. GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 130 U.K. DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 131 U.K. OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 132 U.K. OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 133 U.K. DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 134 U.K. ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 135 U.K. ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 136 U.K. MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 137 U.K. BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 138 U.K. PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 139 U.K. ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 140 U.K. ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 141 U.K. OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 142 U.K. VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 143 U.K. CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 144 U.K. OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 145 U.K. OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 146 U.K. OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 147 U.K. OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 148 U.K. TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 149 U.K. ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 150 U.K. LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 151 U.K. INJECTABLE IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 152 U.K. OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 153 U.K. OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 154 U.K. RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 155 FRANCE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 156 FRANCE DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 157 FRANCE SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 158 FRANCE OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 159 FRANCE VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 160 FRANCE REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 161 FRANCE GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 162 FRANCE DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 163 FRANCE OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 164 FRANCE OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 165 FRANCE DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 166 FRANCE ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 167 FRANCE ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 168 FRANCE MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 169 FRANCE BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 170 FRANCE PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 171 FRANCE ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 172 FRANCE ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 173 FRANCE OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 174 FRANCE VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 175 FRANCE CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 176 FRANCE OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 177 FRANCE OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 178 FRANCE OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 179 FRANCE OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 180 FRANCE TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 181 FRANCE ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 182 FRANCE LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 183 FRANCE INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 184 FRANCE OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 185 FRANCE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 186 FRANCE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 187 HUNGARY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 188 HUNGARY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 189 HUNGARY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 190 HUNGARY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 191 HUNGARY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 192 HUNGARY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 193 HUNGARY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 194 HUNGARY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 195 HUNGARY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 196 HUNGARY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 197 HUNGARY DRUG IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 198 HUNGARY ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 199 HUNGARY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 200 HUNGARY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 201 HUNGARY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 202 HUNGARY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 203 HUNGARY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 204 HUNGARY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 205 HUNGARY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 206 HUNGARY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 207 HUNGARY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 208 HUNGARY OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 209 HUNGARY OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 210 HUNGARY OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 211 HUNGARY OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 212 HUNGARY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 213 HUNGARY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 214 HUNGARY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 215 HUNGARY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 216 HUNGARY OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 217 HUNGARY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 218 HUNGARY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 219 LITHUANIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 220 LITHUANIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 221 LITHUANIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 222 LITHUANIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 223 LITHUANIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 224 LITHUANIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 225 LITHUANIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 226 LITHUANIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 227 LITHUANIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 228 LITHUANIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 229 LITHUANIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 230 LITHUANIA ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 231 LITHUANIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 232 LITHUANIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 233 LITHUANIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 234 LITHUANIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 235 LITHUANIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 236 LITHUANIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 237 LITHUANIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 238 LITHUANIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 239 LITHUANIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 240 LITHUANIA OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 241 LITHUANIA OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 242 LITHUANIA OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 243 LITHUANIA OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 244 LITHUANIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 245 LITHUANIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 246 LITHUANIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 247 LITHUANIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 248 LITHUANIA OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 249 LITHUANIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 250 LITHUANIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 251 AUSTRIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 252 AUSTRIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 253 AUSTRIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 254 AUSTRIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 255 AUSTRIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 256 AUSTRIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 257 AUSTRIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 258 AUSTRIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 259 AUSTRIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 260 AUSTRIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 261 AUSTRIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 262 AUSTRIA ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 263 AUSTRIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 264 AUSTRIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 265 AUSTRIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION))

TABLE 266 AUSTRIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 267 AUSTRIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 268 AUSTRIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 269 AUSTRIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 270 AUSTRIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 271 AUSTRIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 272 AUSTRIA OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 273 AUSTRIA OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 274 AUSTRIA OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 275 AUSTRIA OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 276 AUSTRIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 277 AUSTRIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 278 AUSTRIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 279 AUSTRIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 280 AUSTRIA OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 281 AUSTRIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 282 AUSTRIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 283 IRELAND OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 284 IRELAND DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 285 IRELAND SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 286 IRELAND OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 287 IRELAND VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 288 IRELAND REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 289 IRELAND GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 290 IRELAND DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 291 IRELAND OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 292 IRELAND OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 293 IRELAND DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 294 IRELAND ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 295 IRELAND ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 296 IRELAND MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 297 IRELAND BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 298 IRELAND PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 299 IRELAND ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 300 IRELAND ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 301 IRELAND OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 302 IRELAND VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 303 IRELAND CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 304 IRELAND OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 305 IRELAND OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 306 IRELAND OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 307 IRELAND OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 308 IRELAND TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 309 IRELAND ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 310 IRELAND LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 311 IRELAND INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 312 IRELAND OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 313 IRELAND OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 314 IRELAND RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 315 NORWAY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 316 NORWAY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 317 NORWAY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 318 NORWAY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 319 NORWAY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION))

TABLE 320 NORWAY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 321 NORWAY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 322 NORWAY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 323 NORWAY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 324 NORWAY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 325 NORWAY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 326 NORWAY ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 327 NORWAY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 328 NORWAY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 329 NORWAY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 330 NORWAY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 331 NORWAY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 332 NORWAY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 333 NORWAY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 334 NORWAY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 335 NORWAY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 336 NORWAY OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 337 NORWAY OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 338 NORWAY OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 339 NORWAY OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 340 NORWAY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 341 NORWAY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 342 NORWAY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 343 NORWAY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 344 NORWAY OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 345 NORWAY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 346 NORWAY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 347 POLAND OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 348 POLAND DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 349 POLAND SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 350 POLAND OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 351 POLAND VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 352 POLAND REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 353 POLAND GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 354 POLAND DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 355 POLAND OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 356 POLAND OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 357 POLAND DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 358 POLAND ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 359 POLAND ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 360 POLAND MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 361 POLAND BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 362 POLAND PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 363 POLAND ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 364 POLAND ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 365 POLAND OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 366 POLAND VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 367 POLAND CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 368 POLAND OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 369 POLAND OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 370 POLAND OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 371 POLAND OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 372 POLAND TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 373 POLAND ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 374 POLAND LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 375 POLAND INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 376 POLAND OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 377 POLAND OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 378 POLAND RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 379 ITALY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 380 ITALY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 381 ITALY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 382 ITALY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 383 ITALY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 384 ITALY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 385 ITALY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 386 ITALY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 387 ITALY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 388 ITALY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 389 ITALY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 390 ITALY ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 391 ITALY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 392 ITALY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 393 ITALY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 394 ITALY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 395 ITALY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 396 ITALY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 397 ITALY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 398 ITALY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 399 ITALY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 400 ITALY OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 401 ITALY OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 402 ITALY OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 403 ITALY OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 404 ITALY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 405 ITALY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 406 ITALY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 407 ITALY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 408 ITALY OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 409 ITALY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 410 ITALY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 411 SPAIN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 412 SPAIN DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 413 SPAIN SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 414 SPAIN OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 415 SPAIN VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 416 SPAIN REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 417 SPAIN GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 418 SPAIN DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 419 SPAIN OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 420 SPAIN OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 421 SPAIN DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 422 SPAIN ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 423 SPAIN ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 424 SPAIN MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 425 SPAIN BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 426 SPAIN PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 427 SPAIN ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 428 SPAIN ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 429 SPAIN OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 430 SPAIN VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 431 SPAIN CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 432 SPAIN OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 433 SPAIN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 434 SPAIN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 435 SPAIN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 436 SPAIN TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 437 SPAIN ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 438 SPAIN LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 439 SPAIN INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 440 SPAIN OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 441 SPAIN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 442 SPAIN RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 443 RUSSIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 444 RUSSIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 445 RUSSIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 446 RUSSIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 447 RUSSIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 448 RUSSIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 449 RUSSIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 450 RUSSIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 451 RUSSIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 452 RUSSIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 453 RUSSIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 454 RUSSIA ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 455 RUSSIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 456 RUSSIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 457 RUSSIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 458 RUSSIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 459 RUSSIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 460 RUSSIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 461 RUSSIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 462 RUSSIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 463 RUSSIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 464 RUSSIA OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 465 RUSSIA OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 466 RUSSIA OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 467 RUSSIA OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 468 RUSSIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 469 RUSSIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 470 RUSSIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 471 RUSSIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 472 RUSSIA OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 473 RUSSIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 474 RUSSIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 475 TURKEY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 476 TURKEY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 477 TURKEY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 478 TURKEY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 479 TURKEY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 480 TURKEY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 481 TURKEY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 482 TURKEY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 483 TURKEY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 484 TURKEY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 485 TURKEY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 486 TURKEY ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 487 TURKEY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 488 TURKEY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 489 TURKEY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 490 TURKEY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 491 TURKEY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 492 TURKEY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 493 TURKEY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 494 TURKEY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 495 TURKEY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 496 TURKEY OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 497 TURKEY OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 498 TURKEY OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 499 TURKEY OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 500 TURKEY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 501 TURKEY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 502 TURKEY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 503 TURKEY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 504 TURKEY OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 505 TURKEY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 506 TURKEY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 507 NETHERLANDS OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 508 NETHERLANDS DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 509 NETHERLANDS SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 510 NETHERLANDS OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 511 NETHERLANDS VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 512 NETHERLANDS REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 513 NETHERLANDS GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 514 NETHERLANDS DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 515 NETHERLANDS OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 516 NETHERLANDS OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 517 NETHERLANDS DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 518 NETHERLANDS ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 519 NETHERLANDS ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 520 NETHERLANDS MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 521 NETHERLANDS BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 522 NETHERLANDS PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION))

TABLE 523 NETHERLANDS ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 524 NETHERLANDS ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 525 NETHERLANDS OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 526 NETHERLANDS VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 527 NETHERLANDS CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 528 NETHERLANDS OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 529 NETHERLANDS OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 530 NETHERLANDS OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION)

TABLE 531 NETHERLANDS OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 532 NETHERLANDS TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 533 NETHERLANDS ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 534 NETHERLANDS LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 535 NETHERLANDS INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 536 NETHERLANDS OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 537 NETHERLANDS OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 538 NETHERLANDS RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 539 SWITZERLAND OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 540 SWITZERLAND DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 541 SWITZERLAND SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 542 SWITZERLAND OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 543 SWITZERLAND VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 544 SWITZERLAND REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 545 SWITZERLAND GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 546 SWITZERLAND DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 547 SWITZERLAND OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 548 SWITZERLAND OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 549 SWITZERLAND DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 550 SWITZERLAND ANTI-INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 551 SWITZERLAND ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 552 SWITZERLAND MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 553 SWITZERLAND BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 554 SWITZERLAND PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 555 SWITZERLAND ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 556 SWITZERLAND ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 557 SWITZERLAND OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 558 SWITZERLAND VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 559 SWITZERLAND CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

TABLE 560 SWITZERLAND OPHTHALMOLOGY MARKET, BY DISEASES, 2021-2030 (USD MILLION)

TABLE 561 SWITZERLAND OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 562 SWITZERLAND OPHTHALMOLOGY MARKET, BY DRUG TYPE 2021-2030 (USD MILLION)

TABLE 563 SWITZERLAND OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 564 SWITZERLAND TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 565 SWITZERLAND ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 566 SWITZERLAND LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 567 SWITZERLAND INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 568 SWITZERLAND OPHTHALMOLOGY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 569 SWITZERLAND OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 570 SWITZERLAND RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 571 REST OF EUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2030 (USD MILLION)

Liste des figures

FIGURE 1 EUROPE OPHTHALMOLOGY MARKET: SEGMENTATION

FIGURE 2 EUROPE OPHTHALMOLOGY MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE OPHTHALMOLOGY MARKET: DROC ANALYSIS

FIGURE 4 EUROPE OPHTHALMOLOGY MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE OPHTHALMOLOGY MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE OPHTHALMOLOGY MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE OPHTHALMOLOGY MARKET: DBMR POSITION GRID

FIGURE 8 EUROPE OPHTHALMOLOGY MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 EUROPE OPHTHALMOLOGY MARKET: END USER COVERAGE GRID

FIGURE 10 EUROPE OPHTHALMOLOGY MARKET: SEGMENTATION

FIGURE 11 RISING PREVALENCE OF OPHTHALMIC DISORDERS& INCREASING GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE EUROPE OPHTHALMOLOGY MARKET FROM 2022 TO 2029

FIGURE 12 THE DEVICE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE EUROPE OPHTHALMOLOGY MARKET FROM 2022 TO 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE OPHTHALMOLOGY MARKET

FIGURE 14 EUROPE OPHTHALMOLOGY MARKET: BY PRODUCTS, 2022

FIGURE 15 EUROPE OPHTHALMOLOGY MARKET: BY PRODUCTS, 2023-2030 (USD MILLION)

FIGURE 16 EUROPE OPHTHALMOLOGY MARKET: BY PRODUCTS, CAGR (2023-2030)

FIGURE 17 EUROPE OPHTHALMOLOGY MARKET: BY PRODUCTS, LIFELINE CURVE

FIGURE 18 EUROPE OPHTHALMOLOGY MARKET: BY DISEASES, 2022

FIGURE 19 EUROPE OPHTHALMOLOGY MARKET: BY DISEASES, 2023-2030 (USD MILLION)

FIGURE 20 EUROPE OPHTHALMOLOGY MARKET: BY DISEASES, CAGR (2023-2030)

FIGURE 21 EUROPE OPHTHALMOLOGY MARKET: BY DISEASES, LIFELINE CURVE

FIGURE 22 EUROPE OPHTHALMOLOGY MARKET: BY PRESCRIPTION MODE ,2022

FIGURE 23 EUROPE OPHTHALMOLOGY MARKET: BY PRESCRIPTION MODE, 2023-2030 (USD MILLION)

FIGURE 24 EUROPE OPHTHALMOLOGY MARKET: BY PRESCRIPTION MODE, CAGR (2023-2030)

FIGURE 25 EUROPE OPHTHALMOLOGY MARKET: BY PRESCRIPTION MODE, LIFELINE CURVE

FIGURE 26 EUROPE OPHTHALMOLOGY MARKET: BY DRUG TYPE ,2022

FIGURE 27 EUROPE OPHTHALMOLOGY MARKET: BY DRUG TYPE, 2023-2030 (USD MILLION)

FIGURE 28 EUROPE OPHTHALMOLOGY MARKET: BY DRUG TYPE, CAGR (2023-2030)

FIGURE 29 EUROPE OPHTHALMOLOGY MARKET: BY DRUG TYPE, LIFELINE CURVE

FIGURE 30 EUROPE OPHTHALMOLOGY MARKET: BY ROUTE OF ADMINISTRATION, 2022

FIGURE 31 EUROPE OPHTHALMOLOGY MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)

FIGURE 32 EUROPE OPHTHALMOLOGY MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)

FIGURE 33 EUROPE OPHTHALMOLOGY MARKET : BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 34 EUROPE OPHTHALMOLOGY MARKET: BY END USER, 2022

FIGURE 35 EUROPE OPHTHALMOLOGY MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 36 EUROPE OPHTHALMOLOGY MARKET: BY END USER, CAGR (2023-2030)

FIGURE 37 EUROPE OPHTHALMOLOGY MARKET: BY END USER, LIFELINE CURVE

FIGURE 38 EUROPE OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 39 EUROPE OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 40 EUROPE OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 41 EUROPE OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 42 EUROPE OPHTHALMOLOGY MARKET: SNAPSHOT (2022)

FIGURE 43 EUROPE OPHTHALMOLOGY MARKET: BY COUNTRY (2022)

FIGURE 44 EUROPE OPHTHALMOLOGY MARKET: BY COUNTRY (2023 & 2030)

FIGURE 45 EUROPE OPHTHALMOLOGY MARKET: BY COUNTRY (2022 & 2030)

FIGURE 46 EUROPE OPHTHALMOLOGY MARKET: PRODUCTS (2023-2030)

FIGURE 47 EUROPE OPHTHALMOLOGY MARKET: COMPANY SHARE 2022 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

The Europe ophthalmology market size will be worth USD 23,186.51 million by 2030.
The growth rate of the Europe ophthalmology market is 5.8% in the forecast by 2030.
The major companies in the Europe ophthalmology market are Alcon, Regeneron Pharmaceuticals Inc., Johnson & Johnson, Inc., Reichert, Inc., Novartis AG, Bausch & Lomb Incorporated, HOYA Corporation., The Cooper Companies Inc., Santen Pharmaceutical Co., Ltd., etc.
Products, disease, prescription mode, drug type, route of administration, end-user, and distribution channel are the factors on which the Europe ophthalmology market research is based.
The rising prevalence of ophthalmic disorders & ocular pains & Rise in traumatic injuries are the growth drivers of the Europe ophthalmology market.

Parcourir les pages associées

Banner